Report Categories
View AllRecent Articles
View All
ADTN ADTRAN Q4 2025 EPS beats estimates by 914 percent shares rise 536 percent on investor optimism
The real story behind Foremost FMST valuation 471 20260508
Why Galapagos GLPG leadership matters more than you think Trend Weakens 20260508
Vanguard Energy ETF VDE Positioned for Sustained Outperformance Amid Global Oil Supply Crunch and Geopolitical Volatility
US Jobless Claims Remain Near Historic Lows in Latest Week
US Military Drill in Venezuela Raises Geopolitical Stakes Amid Political Transition
Bloom Energy Shares Surge on 26 Billion Data Center Deal with AI Cloud Provider Nebius
Signos Secures 20M Funding Deepens Dexcom Partnership to Capitalize on GLP1 WeightLoss Trend
Wholesale Inflation Accelerates Producer Price Index Surges 6 Annually in April Fastest Pace Since 2022
Wall Street Ends Mixed as Oil Slides on Iran Deal Hopes Micron Gains 56 GlobalFoundries Drops 9
GTES Q1 2026 Earnings EPS Beat Drives Positive Market Reaction
ANVS Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Costs Persist
Talos Energy Q1 2026 Earnings EPS Beat Drives Positive Market Sentiment
SHW Q1 2026 Earnings EPS Beats Estimates but Stock Slips Slightly
ITT Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Reaction
Kyndryl Holdings Inc KD Q1 2026 Earnings EPS Misses Estimates by 61 Shares Dip 216
Carlyle Group Subordinated Notes CGABL Hold Steady in Narrow Range Near 1665
McKinley Acquisition Corporation Rights MKLYR Surges 40 Rights Trading at 014
Waste Connections WCN Holds Steady Near Resistance as Volume Remains Subdued
PBF Energy Rises 29 Refining Sector Strength Lifts PBF Stock Amid 40 Level Test
TuHURA Biosciences Inc HURA Rises 684 as Price Tests Key Resistance Level
ETD Ethan EPS beats expectations by 16 but shares dip despite strongerthanexpected profit
AR Antero Q4 2025 EPS misses estimates by 166 percent shares dip 094 percent following quarterly earnings release
Apple Inc AAPL Bullish Endorsements Highlight Underappreciated Catalysts Amid Flat YeartoDate Performance
XRTX XORTX Therapeutics posts far wider Q1 2024 loss than estimates shares fall 185 amid elevated RD spending
Exelon Corporation EXC Q1 2026 Earnings Preview Modest Revenue Growth Expected Amid Earnings Pressures Upside Surprise Potential Remains Mixed
INO Inovio Pharmaceuticals beats Q4 2025 earnings estimates by wide margin shares gain 132 percent today